X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13132) 13132
Publication (1288) 1288
Book Review (1022) 1022
Magazine Article (17) 17
Book Chapter (16) 16
Book / eBook (12) 12
Conference Proceeding (11) 11
Dissertation (5) 5
Newsletter (1) 1
Newspaper Article (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12176) 12176
humans (8164) 8164
enterobacteriaceae - drug effects (6242) 6242
anti-bacterial agents - pharmacology (5102) 5102
microbiology (4825) 4825
microbial sensitivity tests (4691) 4691
enterobacteriaceae (4394) 4394
infectious diseases (3506) 3506
male (2706) 2706
female (2697) 2697
pharmacology & pharmacy (2312) 2312
animals (2218) 2218
enterobacteriaceae infections - microbiology (2200) 2200
escherichia-coli (2161) 2161
bacteria (2129) 2129
enterobacteriaceae - isolation & purification (2068) 2068
escherichia coli - drug effects (2053) 2053
beta-lactamases - genetics (1835) 1835
middle aged (1774) 1774
drug resistance, microbial (1743) 1743
enterobacteriaceae infections - drug therapy (1638) 1638
adult (1635) 1635
antibiotics (1574) 1574
anti-bacterial agents - therapeutic use (1570) 1570
aged (1560) 1560
klebsiella-pneumoniae (1544) 1544
beta-lactamases - metabolism (1473) 1473
infections (1369) 1369
drug resistance, bacterial (1315) 1315
enterobacteriaceae - enzymology (1285) 1285
prevalence (1262) 1262
enterobacteriaceae - genetics (1260) 1260
resistance (1234) 1234
epidemiology (1207) 1207
klebsiella pneumoniae - drug effects (1195) 1195
pseudomonas aeruginosa - drug effects (1176) 1176
drug resistance (1170) 1170
escherichia coli (1122) 1122
bacteria - drug effects (1031) 1031
enterobacteriaceae infections - epidemiology (1011) 1011
drug resistance in microorganisms (981) 981
cephalosporins - pharmacology (954) 954
research (947) 947
bacterial proteins - genetics (933) 933
antimicrobial resistance (899) 899
genes (897) 897
drug resistance, multiple, bacterial (893) 893
escherichia coli - isolation & purification (875) 875
escherichia coli - genetics (858) 858
beta-lactamases - biosynthesis (850) 850
plasmids (845) 845
hospitals (825) 825
cross infection - microbiology (807) 807
carbapenems - pharmacology (803) 803
health aspects (798) 798
risk factors (781) 781
adolescent (752) 752
feces - microbiology (749) 749
gram-negative bacteria (749) 749
immunology (746) 746
biochemical phenomena, metabolism, and nutrition (722) 722
beta-lactam resistance (713) 713
abridged index medicus (699) 699
aged, 80 and over (693) 693
e coli (693) 693
gram-negative bacteria - drug effects (681) 681
child (674) 674
analysis (672) 672
infectious disease (670) 670
polymerase chain reaction (669) 669
emergence (654) 654
klebsiella infections - microbiology (651) 651
pathogens (650) 650
escherichia coli - enzymology (642) 642
bacterial infections and mycoses (641) 641
klebsiella pneumoniae - genetics (625) 625
pseudomonas-aeruginosa (622) 622
escherichia coli infections - microbiology (620) 620
staphylococcus - drug effects (613) 613
klebsiella pneumoniae - isolation & purification (608) 608
bacterial proteins - metabolism (601) 601
antimicrobial agents (591) 591
infant (587) 587
beta lactamases (575) 575
risk-factors (573) 573
antibiotic-resistance (564) 564
child, preschool (564) 564
susceptibility (564) 564
identification (563) 563
urinary tract infections - microbiology (562) 562
antibiotic resistance (560) 560
research article (551) 551
retrospective studies (546) 546
strains (545) 545
klebsiella pneumoniae - enzymology (540) 540
staphylococcus aureus - drug effects (537) 537
infection (533) 533
microbial sensitivity tests - methods (530) 530
polycyclic compounds (520) 520
bacteremia (514) 514
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11705) 11705
French (356) 356
German (227) 227
Russian (225) 225
Spanish (173) 173
Japanese (114) 114
Italian (97) 97
Polish (89) 89
Turkish (36) 36
Chinese (32) 32
Romanian (27) 27
Portuguese (24) 24
Czech (15) 15
Slovak (9) 9
Ukrainian (9) 9
Croatian (7) 7
Dutch (6) 6
Swedish (6) 6
Bulgarian (4) 4
Korean (4) 4
Danish (3) 3
Norwegian (3) 3
Finnish (2) 2
Hebrew (2) 2
Hungarian (2) 2
Serbian (2) 2
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Nature, ISSN 0028-0836, 01/2018, Volume 553, Issue 7687, pp. 208 - 211
Inflammatory diseases of the gastrointestinal tract are frequently associated with dysbiosis(1-8), characterized by changes in gut microbial communities that... 
ENTERICA SEROTYPE TYPHIMURIUM | SEROVAR TYPHIMURIUM | CROHNS-DISEASE | INFLAMMATORY RESPONSES | MULTIDISCIPLINARY SCIENCES | ESCHERICHIA-COLI | ULCERATIVE-COLITIS | GROWTH | ELECTRON-ACCEPTOR | CD-HIT | ENTEROBACTERIACEAE | Intestines - drug effects | Inflammation - pathology | Dysbiosis - drug therapy | Molybdenum - metabolism | Tungsten Compounds - therapeutic use | Male | Tungsten Compounds - pharmacology | Dysbiosis - microbiology | Intestinal Mucosa - drug effects | Inflammation - drug therapy | Cell Respiration - drug effects | Female | Colitis - drug therapy | Enterobacteriaceae - growth & development | Inflammation - microbiology | Intestines - pathology | Anaerobiosis - drug effects | Mice, Inbred C57BL | Intestinal Mucosa - microbiology | Enterobacteriaceae - metabolism | Animals | Colitis - microbiology | Gastrointestinal Microbiome - drug effects | Intestines - microbiology | Enterobacteriaceae - drug effects | Mice | Intestinal Mucosa - pathology | Physiological aspects | Colitis | Microbiota (Symbiotic organisms) | Health aspects | Salmonella | Microbial activity | Anaerobic microorganisms | Animal models | Dysbacteriosis | Inflammatory diseases | Microbiota | Microorganisms | E coli | Intestine | Bacteria | Oxidation | Digestive tract | Anaerobic bacteria | Enzymes | Digestive system | Gastrointestinal tract | Inflammation | Metabolism | Gene expression | Molybdenum | Inflammatory bowel disease | Genetic engineering | Binding sites | Index Medicus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 2, pp. 161 - 168
Journal Article
FASEB Journal, ISSN 0892-6638, 07/2008, Volume 22, Issue 7, pp. 2416 - 2426
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 458 - 8
Plasmid-borne colistin resistance mediated by mcr-1 may contribute to the dissemination of pan-resistant Gram-negative bacteria. Here, we show that mcr-1... 
STRAINS | ACINETOBACTER-BAUMANNII | GRAM-NEGATIVE BACTERIA | PHARMACOKINETICS | PSEUDOMONAS-AERUGINOSA | MULTIDISCIPLINARY SCIENCES | ESCHERICHIA-COLI | CRITICALLY-ILL PATIENTS | IN-VITRO SYNERGY | METHANESULFONATE | POLYMYXIN-B | Enterobacter aerogenes - drug effects | Enterobacter aerogenes - genetics | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Microbial Sensitivity Tests | Colistin - pharmacology | Klebsiella pneumoniae - genetics | Drug Resistance, Bacterial - genetics | Drug Therapy, Combination | Escherichia coli Infections - drug therapy | Enterobacter cloacae - drug effects | Enterobacter cloacae - genetics | Ethanolaminephosphotransferase - genetics | Klebsiella Infections - drug therapy | Enterobacteriaceae Infections - microbiology | Bacteremia - drug therapy | Enterobacteriaceae - genetics | Escherichia coli Infections - microbiology | Klebsiella Infections - microbiology | Animals | Escherichia coli - genetics | Enterobacteriaceae - drug effects | Escherichia coli Proteins - genetics | Anti-Bacterial Agents - pharmacology | Mice | Enterobacteriaceae Infections - drug therapy | Klebsiella | Breakpoints | Clarithromycin | Animal models | Colistin | Thigh | Gram-positive bacteria | Drug resistance | Bacteremia | Antibiotics | Cell death | Lysis | Bacteria | Gram-negative bacteria | Index Medicus
Journal Article
Hepatology, ISSN 0270-9139, 05/2012, Volume 55, Issue 5, pp. 1551 - 1561
Epidemiology, risk factors, and clinical effect of infections by multiresistant bacteria in cirrhosis are poorly known. This work was a prospective evaluation... 
PERITONITIS | LIVER-CIRRHOSIS | ACQUIRED INFECTIONS | ESCHERICHIA-COLI | ACQUISITION | RESISTANCE | HEPATORENAL-SYNDROME | SEPSIS | NORFLOXACIN PROPHYLAXIS | GASTROENTEROLOGY & HEPATOLOGY | KLEBSIELLA-PNEUMONIAE | Multivariate Analysis | Prevalence | Prognosis | Community-Acquired Infections - epidemiology | Gram-Positive Bacteria - drug effects | Humans | Middle Aged | Male | Enterobacteriaceae - isolation & purification | Gram-Negative Bacteria - isolation & purification | Liver Cirrhosis - epidemiology | Microbial Sensitivity Tests | Community-Acquired Infections - drug therapy | Drug Resistance, Multiple, Bacterial | Statistics, Nonparametric | Female | Retrospective Studies | beta-Lactamases - metabolism | Bacterial Infections - microbiology | Cross Infection - epidemiology | Liver Cirrhosis - diagnosis | Bacterial Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Risk Factors | Proportional Hazards Models | Cross Infection - drug therapy | Gram-Negative Bacteria - drug effects | Spain - epidemiology | Cross Infection - microbiology | Bacterial Infections - epidemiology | Enterobacteriaceae - drug effects | Survival Analysis | Gram-Positive Bacteria - isolation & purification | Liver Cirrhosis - microbiology | Aged | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Cohort Studies | Bacterial infections | Antibiotics | Mortality | Bacteria | Staphylococcus infections | Nosocomial infections | Epidemiology | Index Medicus
Journal Article
Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 266 - 277
Journal Article